Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety of Treatment Regimens Containing Bedaquiline and Delamanid in the endTB Cohort.
Hewison C, Khan U, Bastard M, Lachenal N, Coutisson S, Osso E, Ahmed S, Khan P, Franke MF, Rich ML, Varaine F, Melikyan N, Seung KJ, Adenov M, Adnan S, Danielyan N, Islam S, Janmohamed A, Karakozian H, Kamene Kimenye M, Kirakosyan O, Kholikulov B, Krisnanda A, Kumsa A, Leblanc G, Lecca L, Nkuebe M, Mamsa S, Padayachee S, Thit P, Mitnick CD, Huerga H. Hewison C, et al. Among authors: kirakosyan o. Clin Infect Dis. 2022 Sep 29;75(6):1006-1013. doi: 10.1093/cid/ciac019. Clin Infect Dis. 2022. PMID: 35028659 Free PMC article.
Is 6 months of bedaquiline enough? Results from the compassionate use of bedaquiline in Armenia and Georgia.
Hewison C, Bastard M, Khachatryan N, Kotrikadze T, Hayrapetyan A, Avaliani Z, Kiria N, Yegiazaryan L, Chumburidze N, Kirakosyan O, Atshemyan H, Qayyum S, Lachenal N, Varaine F, Huerga H. Hewison C, et al. Among authors: kirakosyan o. Int J Tuberc Lung Dis. 2018 Jul 1;22(7):766-772. doi: 10.5588/ijtld.17.0840. Int J Tuberc Lung Dis. 2018. PMID: 29914602
Concomitant Treatment of Chronic Hepatitis C With Direct-Acting Antivirals and Multidrug-Resistant Tuberculosis Is Effective and Safe.
Melikyan N, Huerga H, Atshemyan H, Kirakosyan O, Sargsyants N, Aydinyan T, Saribekyan N, Khachatryan N, Oganezova I, Falcao J, Balkan S, Hewison C. Melikyan N, et al. Among authors: kirakosyan o. Open Forum Infect Dis. 2021 Jan 4;8(2):ofaa653. doi: 10.1093/ofid/ofaa653. eCollection 2021 Feb. Open Forum Infect Dis. 2021. PMID: 33634203 Free PMC article.
Integrating hepatitis C treatment into multidrug-resistant TB care.
Kirakosyan O, Melikyan N, Falcao J, Khachatryan N, Atshemyan H, Oganezova I, Aznauryan A, Yeghiazaryan L, Sargsyants N, Hayrapetyan A, Balkan S, Hewison C, Huerga H. Kirakosyan O, et al. Public Health Action. 2022 Jun 21;12(2):96-101. doi: 10.5588/pha.22.0002. Public Health Action. 2022. PMID: 35734011 Free PMC article.
Management of patients with multidrug-resistant tuberculosis.
Lange C, Aarnoutse RE, Alffenaar JWC, Bothamley G, Brinkmann F, Costa J, Chesov D, van Crevel R, Dedicoat M, Dominguez J, Duarte R, Grobbel HP, Günther G, Guglielmetti L, Heyckendorf J, Kay AW, Kirakosyan O, Kirk O, Koczulla RA, Kudriashov GG, Kuksa L, van Leth F, Magis-Escurra C, Mandalakas AM, Molina-Moya B, Peloquin CA, Reimann M, Rumetshofer R, Schaaf HS, Schön T, Tiberi S, Valda J, Yablonskii PK, Dheda K. Lange C, et al. Among authors: kirakosyan o. Int J Tuberc Lung Dis. 2019 Jun 1;23(6):645-662. doi: 10.5588/ijtld.18.0622. Int J Tuberc Lung Dis. 2019. PMID: 31315696 Review.
Effectiveness of a bedaquiline, linezolid, clofazimine "core" for multidrug-resistant tuberculosis.
Zeng C, Hernán MA, Trevisi L, Sauer S, Mitnick CD, Hewison C, Bastard M, Khan P, Seung KJ, Rich ML, Law S, Kikvidze M, Kirakosyan O, Miankou A, Thit P, Mamsa S, Janmohamed A, Melikyan N, Ahmed S, Vargas D, Binegdie AB, Temirova K, Oyewusi L, Philippe K, Vilbrun SC, Khan U, Huerga H, Franke MF; endTB Observational Study Team. Zeng C, et al. Among authors: kirakosyan o. medRxiv [Preprint]. 2024 Jan 19:2024.01.18.24301453. doi: 10.1101/2024.01.18.24301453. medRxiv. 2024. PMID: 38293100 Free PMC article. Preprint.